Literature DB >> 27365815

A clinical evaluation of midface advancement using intraoral distractors in management of bone stock deficiencies.

Ramen Sinha1, P Suresh Menon2, M G Venugopal3.   

Abstract

BACKGROUND: Cleft lip and palate patients present large osseous defects of the alveolus and midface hypoplasia. Traditional orthognathic surgery has limitations of relapse and limited age group. Distraction osteogenesis (DO) as a modality for midface advancement is relatively new. Modular internal distractor (MID) offers the advantage of patient compliance and minimal discomfort. The purpose of this study was to evaluate the versatility of intraoral distractors in midface advancement.
METHOD: Nineteen patients with midface bone stock deficiency were selected for maxillary advancement. At the first surgery under general anaesthesia, after the osteotomy (Le Fort I/II), MID system was used. After distraction, evaluation was done for ease of the procedure, stability, and complications. Lateral cephalograms were evaluated at three stages: T1, pre-distraction; T2, post-distraction; and T3, one year post-distraction.
RESULTS: Significant changes showed 13.3 mm mean midface advancement bone formation at the pterygomaxillary region. The results were stable even at one year follow-up.
CONCLUSION: Maxillary position improved in relation to the cranial base. This study showed that the MID was versatile in midface advancement in stability and patient compliance with minimal complications.

Entities:  

Keywords:  distraction osteogenesis (DO); maxillary hypoplasia; midface advancement

Year:  2011        PMID: 27365815      PMCID: PMC4920832          DOI: 10.1016/S0377-1237(11)60051-8

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  15 in total

1.  Mandibular distraction osteogenesis: a historic perspective and future directions.

Authors:  J B Cope; M L Samchukov; A M Cherkashin
Journal:  Am J Orthod Dentofacial Orthop       Date:  1999-04       Impact factor: 2.650

2.  Maxillary distraction osteogenesis for cleft lip and palate children using an external, adjustable, rigid distraction device: a report of 2 cases.

Authors:  K Harada; Y Baba; K Ohyama; S Enomoto
Journal:  J Oral Maxillofac Surg       Date:  2001-12       Impact factor: 1.895

3.  Radiographic evaluation of bone formation in the pterygoid region after maxillary distraction with a rigid external distraction (RED) device.

Authors:  B Kusnoto; A A Figueroa; J W Polley
Journal:  J Craniofac Surg       Date:  2001-03       Impact factor: 1.046

Review 4.  Midfacial distraction osteogenesis.

Authors:  George K B Sándor; Leena P Ylikontiola; Willy Serlo; Pertti M Pirttiniemi; Robert P Carmichael
Journal:  Atlas Oral Maxillofac Surg Clin North Am       Date:  2008-09

5.  Ultrasound monitoring of distraction osteogenesis.

Authors:  C W Hughes; R W Williams; M Bradley; G H Irvine
Journal:  Br J Oral Maxillofac Surg       Date:  2003-08       Impact factor: 1.651

6.  Management of severe maxillary deficiency in childhood and adolescence through distraction osteogenesis with an external, adjustable, rigid distraction device.

Authors:  J W Polley; A A Figueroa
Journal:  J Craniofac Surg       Date:  1997-05       Impact factor: 1.046

7.  Maxillary distraction osteogenesis: a method with skeletal anchorage.

Authors:  G Swennen; T Dujardin; A Goris; A De Mey; C Malevez
Journal:  J Craniofac Surg       Date:  2000-03       Impact factor: 1.046

8.  Rigid external distraction osteogenesis for a patient with maxillary hypoplasia and oligodontia.

Authors:  Noriyuki Kitai; Keishi Kawasaki; Yoshitaka Yasuda; Mikihiko Kogo; Shumei Murakami; Sven Kreiborg; Kenji Takada
Journal:  Cleft Palate Craniofac J       Date:  2003-03

9.  Distraction osteogenesis for the cleft lip and palate patient.

Authors:  Fernando Molina
Journal:  Clin Plast Surg       Date:  2004-04       Impact factor: 2.017

10.  Distraction osteogenesis in maxillofacial surgery using internal devices: review of five cases.

Authors:  M Chin; B A Toth
Journal:  J Oral Maxillofac Surg       Date:  1996-01       Impact factor: 1.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.